STOCK TITAN
  1. Home
  2. Sec-filings
  3. TDOC
  4. [Form 4] Teladoc Health, Inc. Insider Trading Activity

[Form 4] Teladoc Health, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Teladoc Health, Inc. executive Fernando M. Rodrigues, President of BetterHelp, reported multiple stock transactions involving common shares and restricted stock units. He sold 16,314 common shares at $5.117 per share and 25,086 shares at $4.982 per share, totaling 41,400 shares sold.

Footnotes state these shares were sold to cover tax withholding obligations tied to vesting of restricted stock units and were executed under a Rule 10b5-1 trading plan adopted on November 3, 2025. Rodrigues also reported grants and exercises of restricted stock units, including 181,661 units granted on March 1, 2026, which each represent a contingent right to receive one share of Teladoc common stock and vest over time in scheduled installments.

Positive

  • None.

Negative

  • None.
Insider Rodrigues Fernando M.
Role President of BetterHelp
Sold 41,400 shs ($208K)
Approx. gross sale proceeds $208K
Approx. exercise cost $0.00
Type Security Shares Price Value
Sale Common Stock 25,086 $4.982 $125K
Sale Common Stock 16,314 $5.117 $83K
Grant/Award Restricted Stock Units 181,661 $0.00 $0.00
Exercise Restricted Stock Units 5,491 $0.00 $0.00
Exercise Restricted Stock Units 1,042 $0.00 $0.00
Exercise Restricted Stock Units 34,867 $0.00 $0.00
Exercise Common Stock 5,491 $0.00 $0.00
Exercise Common Stock 1,042 $0.00 $0.00
Exercise Common Stock 34,867 $0.00 $0.00
Holdings After Transaction: Restricted Stock Units — 272,039 shares (Direct); Common Stock — 0 shares (Direct)
Footnotes (8)
  1. F1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  2. F2. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
  3. F3. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 3, 2025.
  4. F4. On December 1, 2023, the reporting person was granted 65,894 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  5. F5. On March 19, 2024, the reporting person was granted 12,500 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
  6. F6. On March 1, 2025, the reporting person was granted 104,602 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  7. F7. Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
  8. F8. One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rodrigues Fernando M.
(Last) (First) (Middle)
C/O TELADOC HEALTH, INC.,
155 E 44TH ST, SUITE 1700
(Street)
NEW YORK NY 10017
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Teladoc Health, Inc. [ TDOC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President of BetterHelp
3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/27/2026 M 5,491 A (1) 5,491 D
Common Stock 02/27/2026 M 1,042 A (1) 6,533 D
Common Stock 02/27/2026 M 34,867 A (1) 41,400 D
Common Stock 03/02/2026 S 16,314(2) D $5.117 25,086 D
Common Stock 03/03/2026 S(3) 25,086 D $4.982 0 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 02/27/2026 M 5,491 (4) (4) Common Stock 5,491 $0 16,475 D
Restricted Stock Units (1) 02/27/2026 M 1,042 (5) (5) Common Stock 1,042 $0 4,168 D
Restricted Stock Units (1) 02/27/2026 M 34,867 (6) (6) Common Stock 34,867 $0 69,735 D
Restricted Stock Units (7) 03/01/2026 A 181,661 (8) (8) Common Stock 181,661 $0 181,661 D
Explanation of Responses:
1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
2. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
3. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 3, 2025.
4. On December 1, 2023, the reporting person was granted 65,894 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
5. On March 19, 2024, the reporting person was granted 12,500 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
6. On March 1, 2025, the reporting person was granted 104,602 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
7. Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
8. One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Remarks:
/s/ Adam C. Vandervoort, Attorney-in-Fact 03/03/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR